Kirsten L. Bryant
University of North Carolina at Chapel Hill(US)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Advanced Breast Cancer Therapies, Colorectal Cancer Treatments and Studies, Cancer, Hypoxia, and Metabolism, Cancer-related Molecular Pathways
Most-Cited Works
- → Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer(2019)699 cited
- → KRAS: feeding pancreatic cancer proliferation(2014)677 cited
- → Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells(2011)491 cited
- → Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth Suppression(2015)271 cited
- → Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer(2019)213 cited
- → KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism(2018)189 cited
- → KRAS Mutant Pancreatic Cancer: No Lone Path to an Effective Treatment(2016)180 cited
- → Combination Therapies with CDK4/6 Inhibitors to Treat KRAS- Mutant Pancreatic Cancer(2022)147 cited
- → Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers(2024)91 cited
- → The Sustained Induction of c-MYC Drives Nab-Paclitaxel Resistance in Primary Pancreatic Ductal Carcinoma Cells(2019)83 cited